Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

NACompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Conditions
Macular Degeneration
Interventions
DRUG

pegaptanib sodium

Trial Locations (20)

11021

L.I. Vitreo-Retinal Consultants, Great Neck

21740

Cumberland Valley Retina Center, Hagerstown

29204

Palmetto Retina Center, Columbia

33901

Retina Health Center, Fort Myers

44107

Retina Associates of Cleveland Inc., Lakewood

48073

Associated Retinal Consultants, Royal Oak

64108

Eye Foundation of Kansas City, Kansas City

70155

Retina Associates, New Orleans

73104

Dean A. McGee Eye Institute, Oklahoma City

78503

Valley Retina Associates, P.A., McAllen

90033

Doheny Eye Institute, Los Angeles

97239

The Casey Eye Institute, Portland

06606

Connecticut Retina Consultants, L.L.C., Bridgeport

06518

New England Retina Associates, Hamden

02111

New England Eye Center, Boston

02114

Ophthalmic Consultants of Boston, Boston

03301

The Eye Center of Concord, Concord

07109

Vitreo- Retinal Assoc. of NJ, Belleville

07666

Retina Associates of New Jersey, P.A., Teaneck

05401

University of Vermont College of Medicine, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eyetech Pharmaceuticals

INDUSTRY